# Cardiovascular Protective Effect of Spironolactone in Hemodialysis

> **NCT00277693** · PHASE4 · UNKNOWN · sponsor: **Universidad de los Andes, Chile**

## Conditions studied

- Hemodialysis

## Interventions

- **DRUG:** Spironolactone (drug)

## Key facts

- **NCT ID:** NCT00277693
- **Lead sponsor:** Universidad de los Andes, Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2006-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00277693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00277693, "Cardiovascular Protective Effect of Spironolactone in Hemodialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00277693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*